Learn more about select studies for your patients now available at Cleveland Clinic Children’s.Read More
Combined SBRT + pazopanib combination is well tolerated with several benefits for select patients with pediatric sarcoma, a new study finds. Radiation oncologist Erin Murphy, MD, discusses the study.
More than one-third of pediatric and adolescent patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) experienced disease progression within two years, despite standard-of-care lifestyle counseling, according to a recent study.
Research is an integral part of the mission of Cleveland Clinic Children’s. This article provides an overview of selected clinical studies.
Stereotactic radiosurgery offers hope to adolescent and young adults with metastatic sarcoma in the spine, according to a new study. Radiation oncologist Erin Murphy, MD, discusses the research, and why it’s important to be thoughtful about concurrent therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The use of sodium thiosulfate to prevent hearing loss in children treated with cisplatin appears promising, according to recent studies, but more research is needed. Pediatric oncologist Stefanie Thomas, MD, MS, explains.
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children worldwide. But RSV doesn’t affect all children in the same way. In this article, pediatric pulmonologist Fabria Rezaee, MD, discusses her study that suggests air pollution may intensify RSV symptoms.
A pacuity of models hinders the development of treatments for Ewing sarcoma, a common and deadly pediatric cancer involving bone and soft tissues. To remedy this, researchers are creating zebrafish models that will enable the study of the biology of Ewing sarcoma.
A substantial number of patients with attention deficit and hyperactivity disorder do not achieve a stable medication dose right away. Michael Manos, PhD, discusses titration strategies and how pediatricians can support families through the process.
A new study supports using bivalirudin, a direct thrombin inhibitor, as an alternative to heparin in pediatric ECMO. Pediatric critical care medicine specialist Mohammed Hamzah, MD, discusses his research, as well as the benefits and costs of this treatment.
Excellent acute success rates, low procedural complications and low recurrence risk with ablation for Wolff-Parkinson-White syndrome, according to the results of a new study. Routine follow-up remains necessary despite the curative nature of ablation, explains pediatric electrophysiologist Peter Aziz, MD.